haloperidole

DRUG3 trials

Sponsors

Sykehuset Innlandet HF, Janssen Scientific Affairs, LLC, Ortho-McNeil Janssen Scientific Affairs, LLC

Conditions

DementiaSchizophrenia

Phase 4

Discontinuation of Antipsychotics and Antidepressants Among Patients With BPSD

CompletedNCT00433121

Sykehuset Innlandet HFDementia

Start: 2006-09-30End: 2007-08-31Updated: 2007-08-24

15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated

CompletedNCT01157351

Janssen Scientific Affairs, LLCSchizophrenia

Start: 2010-05-31End: 2013-12-31Updated: 2015-04-24

Twelve Month Study Comparing Paliperidone Palmitate and Select Oral Antipsychotics in Adults With Schizophrenia Who Have Been Recently Discharged From an Inpatient Psychiatric Hospital

WithdrawnNCT01193166

Ortho-McNeil Janssen Scientific Affairs, LLCSchizophrenia

Start: 2010-08-31End: 2012-09-30Updated: 2013-07-08

Related Papers

Earlier Use of Long-Acting Injectable Paliperidone Palmitate Versus Oral Antipsychotics in Patients With Schizophrenia

The Journal of Clinical Psychiatry2023-09-212 citations

Treatment Effect With Paliperidone Palmitate Compared With Oral Antipsychotics in Black/African American Patients With Schizophrenia and a History of Criminal Justice System Involvement

The Journal of Clinical Psychiatry2021-02-231 citations

Projecting the Potential Effect of Using Paliperidone Palmitate Once-Monthly and Once-Every-3-Months Long-Acting Injections Among Medicaid Beneficiaries with Schizophrenia.

2018-08-018 citations

Once-monthly paliperidone palmitate compared with conventional and atypical daily oral antipsychotic treatment in patients with schizophrenia.

2016-09-1514 citations

A pragmatic analysis comparing once-monthly paliperidone palmitate versus daily oral antipsychotic treatment in patients with schizophrenia

Schizophrenia Research2015-12-2932 citations

Treatment effect with paliperidone palmitate compared with oral antipsychotics in patients with recent-onset versus more chronic schizophrenia and a history of criminal justice system involvement.

2015-09-2516 citations

Real-World Outcomes of Paliperidone Palmitate Compared to Daily Oral Antipsychotic Therapy in Schizophrenia

The Journal of Clinical Psychiatry2015-04-14133 citations

Le traitement mensuel par palmitate de paliperidone (PP) versus les traitements antipsychotiques oraux journaliers retarde les conséquences négatives de la schizophrénie en « vie réelle » (étude PRIDE)

European Psychiatry2014-11-01

Design and Rationale of the Paliperidone Palmitate Research in Demonstrating Effectiveness (PRIDE) Study

The Journal of Clinical Psychiatry2014-10-2727 citations